therapy – Page 446 – Communicable Diseases Research

SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping

Review

Published on 2020-06-102022-10-29
Journal: Journal of Inflammation (London, England) [Category] COVID-19,

Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?

Review

Published on 2020-06-102022-10-31
Journal: Nutrients [Category] COVID-19, SARS,

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-102022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 Administered age antibiotic antiviral efficacy Asthma Azithromycin Beta blocker blinded block calcium cardiovascular change changed chronic clinical combination therapy Control control group coordinator COPD COVID-19 COVID-19 test Day days alive death derivative Diagnosis Direct Current discharged disorder dissemination double-blind study ECG element ergot alkaloid expected Final FiO2 generate Glucose glucose-6-phosphate dehydrogenase deficiency guide hearing loss hematological hospital hospitalisation Hospitalization hospitals Hydroxychloroquine hypersensitivity impede Inclusion Informed consent intensive care Interstitial lung disease Intervention intervention group invasive ventilation investigated investigator Liver disease lung maculopathy medication mental illness modulation myasthenia gravis negative pregnancy test network Neurogenic neurological number objective offered outcome parallel group participant Patient patients with COVID-19 Placebo pregnant Primary outcome problem protocol psoriasis pulmonary QTc QTc interval randomisation randomised randomised controlled trial receive recruited recruitment reduce Registered reported respiratory infections retinopathy risk Sample size sequence significantly Sponsor Standard standard care standard treatment status Stratification Study protocol the patient therapy treated Treatment Trial Visual field website women
[DOI] 10.1186/s13063-020-04409-9 PMC 바로가기 [Article Type] Letter

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology, Outcomes, and Management

Cardiology

Published on 2020-06-102022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] ACE-2 acute respiratory syndrome angiotensin-converting enzyme 2 anti-viral agents cardiac damage cardiac monitoring Cardiomyopathy cardiovascular cardiovascular complication cardiovascular damage cause caused clinical outcomes Complication convalescent serum coronavirus 2 coronavirus disease Coronavirus-2 COVID-19 COVID-19 patient detect develop disease drug etiology fibrosis healthcare worker help hospitalized COVID-19 patient hypoxia immune response inflammatory state information inhibitors Injury Intention interferon interleukin-6 limit management monitoring mortality rate Myocardial infarction myocardial injury Notch pandemic pathophysiology Patient Percutaneous coronary intervention receptor respiratory safety profile SARS-CoV-2 sensitivity severe complication signaling pathway Standard of care systemic inflammation Takotsubo the disease therapy Treatment
[DOI] 10.7759/cureus.8543 PMC 바로가기 [Article Type] Cardiology

Misinformation about spinal manipulation and boosting immunity: an analysis of Twitter activity during the COVID-19 crisis

Research

Published on 2020-06-092022-10-31
Journal: Chiropractic & manual therapies [Category] Coronavirus, SARS,

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Research

Published on 2020-06-092022-10-05
Journal: Nature [Category] SARS, 비임상, 임상, 진단, 치료제,

[키워드] acute respiratory syndrome animal model animal models Antiviral approved authorization benefit Bronchoalveolar lavage clinical clinical benefit clinical trial coronavirus coronavirus disease COVID-19 drug effective Efficacy Emergency first dose food GS-5734 in vivo infected with SARS-CoV-2 Infection inhibited initiated investigated lack lung damage lung viral load macaque MERS-CoV Middle East nucleotide patients with COVID-19 Pneumonia potential treatments preclinical data Prevent progression pulmonary infiltrate reduced Remdesivir Replication Repurposed drug respiratory syndrome coronavirus rhesus rhesus macaque SARS-CoV-2 severe disease suggested Support therapy treat treated Treatment upper respiratory tract Virus shedding virus titre while
[DOI] 10.1038/s41586-020-2423-5 [Article Type] Research

Management of Hemoglobin Disorders During the COVID-19 Pandemic

Medicine

Published on 2020-06-092022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics

급성호흡곤란증후군의 간엽줄기세포치료제: 기초부터 임상까지

Review

Published on 2020-06-092022-09-10
Journal: Protein & Cell [Category] MERS, SARS, 비임상,

[키워드] 2019 novel coronavirus 2019 novel coronavirus disease acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 alveolar fluid clearance anti-apoptotic Anti-inflammatory approaches ARDS Bacterial breath caused Cell cell damage Cell therapy China clinical study clinics coronavirus coronavirus disease COVID-19 COVID-19 patient develop disease disrupt distal Effects Efficacy ENhance epithelial epithelial cell event Extracellular vesicles Factor high mortality intrinsic limit lung mechanism mesenchymal stem cell Mesenchymal stem cells morbidity MSC MSC therapy multiple organ failure Novel coronavirus novel coronavirus disease occurred optimization Organ failure organ injury paracrine pathophysiological patients with ARDS Pneumonia promote pulmonary endothelial respiratory respiratory distress SARS-CoV-2 SARS-CoV-2-infected patient SARS-CoV-2-infected patients severe acute respiratory syndrome Coronavirus severe pneumonia stem cell supportive care survival syndrome therapeutic therapy variety
[DOI] 10.1007/s13238-020-00738-2 PMC 바로가기 [Article Type] Review

Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children

Research Article

Published on 2020-06-092022-10-28
Journal: BMC Pediatrics [Category] Coronavirus, SARS,

[키워드] albumin Allogeneic Analysis Autoimmune disease calculated cause cell transplantation children clinician Dexamethasone Diagnosis Disease progression EBV excluded Factor hazard ratio HCT hemoglobin hemophagocytic lymphohistiocytosis HLH Hyperinflammatory syndrome identify immunodeficiency Infection malignancy median age medical record outcome parameter Patient patients Pediatric patient Platelet Predictive prognostic Prognostic factor Prognostic factor, risk stratification regimen Result risk secondary hemophagocytic lymphohistiocytosis survival survival analysis Therapies therapy Treatment Treatment response virus
[DOI] 10.1186/s12887-020-02178-7 PMC 바로가기 [Article Type] Research Article

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

Review Article

Published on 2020-06-082022-10-31
Journal: Clinics [Category] COVID-19, MERS, SARS,